Cancer antigen, cancer therapy, and cancer diagnosis
US4132769A · kind A · utility
39Cited by
8References
15Claims
0Family size
Inventor
Key dates
| Filing date | Oct 28, 1975 |
| Grant date | Jan 2, 1979 |
| Priority date | — |
| Expiry date | Oct 28, 1995 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/83
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
A novel human cancer associated protein, termed C1 IAC, having C1 inactivator-like function, diagnostic tests based on demonstrating the presence of C1 IAC, antibodies and antisera with specificity against C1 IAC, matrix-immobilized antibodies, and the therapy of human cancer using antisera or antibodies with specificity against C1 IAC. Also, a novel human cancer associated protein, termed CAAC, and antisera and antibodies with specificity against CAAC. The use of rabbit antihuman C1 IA and antihuman C4 for monitoring cancer diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.